Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication

Fibroblast growth factor 21 (FGF-21), previously recognized as a marker of liver damage and a potential drug target in non-alcoholic fatty liver disease (NAFLD), has unclear implications in hepatitis C virus (HCV) infections. This study aimed to investigate the relationship between FGF-21 levels and...

Descripción completa

Detalles Bibliográficos
Autores principales: Biagi, Filippo, Carlomagno, Francesco, Carbone, Martina, Veralli, Roberta, Vespasiani-Gentilucci, Umberto, Riva, Elisabetta, Manfrini, Silvia, Tuccinardi, Dario, De Santis, Adriano, Gnessi, Lucio, Watanabe, Mikiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673401/
https://www.ncbi.nlm.nih.gov/pubmed/37999215
http://dx.doi.org/10.3390/metabo13111119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673401/
https://www.ncbi.nlm.nih.gov/pubmed/37999215
http://dx.doi.org/10.3390/metabo13111119

Ejemplares similares